Articles related to GENDER-AFFIRMING CARE

Gender-affirming surgery, while beneficial in affirming gender identity, is associated with increased risk of mental health issues, underscoring the need for ongoing, gender-sensitive mental health support for transgender individuals’ post-surgery.

Analysis of more than 5 million adolescent insurance claims reveals that gender-affirming medication prescriptions remain exceptionally rare, with peak rates reaching only 140.16 per 100,000 at age 17 for AFAB adolescents.

Current evidence indicates positive mental health outcomes with gender-affirming care, with studies showing decreased rates of depression, self-harm, and suicidal ideation among treated adolescents.

The Hein case has ignited a national debate on the ethics of gender-affirming care for minors, raising questions about informed consent and the role of healthcare providers in these complex decisions.

Explore a course created to equip pharmacists with the knowledge and abilities to assist patients who identify as transgender or gender nonconforming (TGND). The educational program “Gender-Affirming Care in Pharmacy Practice” is a comprehensive guide for pharmacists to better serve transgender and gender-diverse (TGD) patients. It provides a deep understanding of the terminology related to TGD patient populations, including definitions of gender identity, gender expression, and various gender identities. The program emphasizes the importance of gender-affirming care, which includes social, medical, psychological, and behavioral care that aligns with a person’s gender identity. It also provides guidance on how to communicate inclusively with TGD patients, such as introducing oneself with name and pronouns, asking open-ended questions, and avoiding unnecessary or invasive questions. Furthermore, the program highlights the health disparities faced by TGD individuals seeking gender-affirming care, such as higher levels of unemployment and healthcare discrimination. It also discusses the coverage of gender-affirming care by Medicaid, which varies across states. The program provides detailed information on hormone therapy for TGD patients, including testosterone and estrogen hormone therapy. It discusses the potential side effects, contraindications, and the importance of contraception for patients at risk of becoming pregnant while on testosterone therapy. Lastly, the […]